Efficacy and Safety of TQB2450 Injection Combined With Chemotherapy ± Anlotinib Hydrochloride Capsules for Advanced Endometrial Cancer or Sarcoma of Uterus.

Stopped Per sponsor request. Premature closure was not prompted by any safety or efficacy concerns.

Conditions

• Advanced Endometrial Cancer
• Sarcoma of Uterus

Interventions

• DRUG: TQB2450 injection
• DRUG: Anlotinib Hydrochloride Capsule
• DRUG: Carboplatin Injection
• DRUG: Paclitaxel Injection
• DRUG: Doxorubicin Hydrochloride Injection
• DRUG: Gemcitabine Hydrochloride Injection
• DRUG: Docetaxel injection

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.